Anzeige
Mehr »
Login
Sonntag, 24.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Microsofts, Googles und Amazons nukleares Wettrennen macht diese Uranaktie zu einem Muss!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D7B2 | ISIN: KYG6096M1226 | Ticker-Symbol: A1V0
NASDAQ
22.11.24
22:00 Uhr
0,740 US-Dollar
+0,004
+0,54 %
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
APTORUM GROUP LIMITED Chart 1 Jahr
5-Tage-Chart
APTORUM GROUP LIMITED 5-Tage-Chart

Aktuelle News zur APTORUM GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.11.Aptorum Group Stock Hits 52-Week Low at $1.2 Amid Market Challenges3
APTORUM GROUP Aktie jetzt für 0€ handeln
08.11.Aptorum Group announces annual shareholder meeting details2
08.11.Aptorum Group Ltd - 6-K, Report of foreign issuer2
05.11.Aptorum stock hits 52-week low at $1.34 amid market challenges2
01.11.Aptorum Group Ltd - 6-K, Report of foreign issuer1
28.10.Aptorum Group stock hits 52-week low at $1.35 amid market challenges1
09.08.Aptorum Group Ltd - 6-K, Report of foreign issuer1
26.07.Aptorum Group Ltd - S-8, Securities to be offered to employees in employee benefit plans1
31.05.Aptorum Group Ltd - 6-K, Report of foreign issuer2
30.04.Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update361Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group" or "We"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases...
► Artikel lesen
06.03.Aptorum Group Limited: Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy Business533Aptorum Group Limited (Nasdaq: APM), a clinical stage biopharmaceutical company ("Aptorum"), and privately-held YOOV Group Holding Ltd. ("YOOV") jointly announced today that they entered into an Agreement...
► Artikel lesen
13.02.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 11.174The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameBE0003545531 SOLVAC...
► Artikel lesen
22.12.23Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023666Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases...
► Artikel lesen
21.12.23Aptorum Group Limited Announces Results of 2023 Annual General Meeting of Shareholders362Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1